200 likes | 565 Views
OPTIME CHF. OPTIME CHF: Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure The OPTIME CHF trial was designed to evaluate whether intravenous treatment with milrinone (a bipyridine inotropic/vasodilator that improves hemodynamics in the short term), i
E N D